National Cancer Institute/NIH/DHHS

Funding Organization

Awards Grant

  • 1/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership
  • 1/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership - Administrative Core
  • 1/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership - Pilot Project #1
  • 1/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership - Pilot Project #2
  • 1/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership - Training and Education
  • 3/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership - Research Projects
  • 3/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Partnership - Pilot Project: Racial Disparities in Lung Cancer Screening Among a High-Risk Population at a Community Hospital and Academic Health System in the Southeastern US
  • 3/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Partnership - Admin Core
  • 3/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Partnership - Bioethics Shared Resource
  • 3/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Partnership - Biostatistics/Bioinformatics
  • 3/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Partnership - Outreach Core
  • 3/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Partnership - Planning and Evaluation Core
  • 3/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Partnership - Project 1 - Elucidating the Role of AAA ATPase TRIP13 in Prostate Cancer
  • 3/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Partnership - Project 2 - Chemotherapy-induced Immunomodulation in Colon Cancer
  • 3/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Partnership - Research Education Core
  • 3/3 Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership
  • 3/3 Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership - Investigating Race-Related Microbial Influences in Triple Negative Breast Cancer
  • 3/3 Morehouse School of Medicine/Tuskegee University/University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Partnership
  • 3D-Microtumor_GBM Xenoline Proband Modeling of Kinome-Directed Therapy
  • A Druggable Chromatin Modifier Pathway in HCC
  • A Genome-Wide Methylation Study of Epigenetic Contributions to Multiple Myeloma
  • A Mixed Methods Study Examining Early Onset Anal Cancer and Current Screening Practices, Attitudes, and Perceived Risk Among People Living With and Without HIV in the Deep South
  • A Motion Exergaming Approach to Promote Self-Managing Fatigue and Pain after Head and Neck Cancer Treatment
  • A Multi-Component Non-Pharmacological Intervention to Improve Cognitive Outcomes in Hematologic Cancer Survivors
  • A Novel Anoikis Effector that Drives Ovarian Cancer Metastasis
  • A Novel Druggable Genetic Vulnerability Pathway in Melanoma
  • A Novel Epigenetic Immunotherapy for Ovarian Cancer Treatment
  • A Novel, Transferable Sialylation-mediated Mechanism of Chemoradioresistance in GI Cancer
  • A Phase 1 Study of M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma
  • A Phase I Study to Evaluate the Safety and Immunogenicity of HPV 16 L2 11-200
  • A Randomized Phase II Trial of Flibanserin in Men Receiving Androgen Suppression for Prostate Cancer
  • A20 Promotes Glioma Stem Cell Mediated Tumorigenesis
  • Accurate DCE-MRI Measurement of Glioblastoma using Point-of-care Portable Perfusion Phantom
  • Active - Administrative Core - Comprehensive Cancer Center Core Support Grant
  • Active - Biostatistics and Bioinformatics - Comprehensive Cancer Center Core Support Grant
  • Active - Comprehensive Cancer Center Core Support Grant - Alabama HPV Vaccination Coalition Supplement
  • Active - Comprehensive Cancer Center Core Support Grant - Comprehensive Genomics SF (Hudson Alpha)
  • Active - Comprehensive Genomics Shared Facility - Comprehensive Cancer Center Core Support Grant
  • Active - Data Safety and Monitoring - Comprehensive Cancer Center Core Support Grant
  • Active - Developmental Funds - Comprehensive Cancer Center Core Support Grant
  • Active - High Resolution Imaging - Comprehensive Cancer Center Core Support Grant
  • Active - Human Imaging - Comprehensive Cancer Center Core Support Grant
  • Active - Major Program Leader - Comprehensive Cancer Center Core Support Grant
  • Active - NCI Clinical Trial Reporting Program - Comprehensive Cancer Center Core Support Grant
  • Active - Planning and Evaluation - Comprehensive Cancer Center Core Support Grant
  • Active - Proteomics - Comprehensive Cancer Center Core Support Grant
  • Active - Protocol Review & Monitoring - Comprehensive Cancer Center Core Support Grant
  • Active - Protocol Specific Research Support - Comprehensive Cancer Center Core Support Grant
  • Active - Recruitment & Retention - Comprehensive Cancer Center Core Support Grant
  • Active - Self-Collection & HPV Testing in Unscreened Women: A Feasibility Study in Brazil - Comprehensive Cancer Center Core Support Grant
  • Active - Senior Leadership - Comprehensive Cancer Center Core Support Grant
  • Active - Small Animal Imaging - Comprehensive Cancer Center Core Support Grant
  • Active - Structural Bilology SF Molecular NMR - Comprehensive Cancer Center Core Support Grant
  • Active - Structural Biology SF X-Ray Crystallography - Comprehensive Cancer Center Core Support Grant
  • Active - Tissue Procurement - Comprehensive Cancer Center Core Support Grant
  • Adaptation and Evaluation of a Culturally- and Gender-Relevant Tobacco Cessation Among Women in Brazil: An Integrated mHealth Approach
  • Adapting MultiPLe Behavior Interventions that eFfectively Improve (AMPLIFI) Cancer Survivor Health
  • Adapting MultiPLe Behavior Interventions that eFfectively Improve (AMPLIFI) Cancer Survivor Health - ADI Core
  • Adapting MultiPLe Behavior Interventions that eFfectively Improve (AMPLIFI) Cancer Survivor Health - Administrative Core
  • Adapting MultiPLe Behavior Interventions that eFfectively Improve (AMPLIFI) Cancer Survivor Health - Assessment Core
  • Adapting MultiPLe Behavior Interventions that eFfectively Improve (AMPLIFI) Cancer Survivor Health - Project 1
  • Adapting MultiPLe Behavior Interventions that eFfectively Improve (AMPLIFI) Cancer Survivor Health - Project 2
  • Adapting MultiPLe Behavior Interventions that eFfectively Improve (AMPLIFI) Cancer Survivor Health - Recruitment Core
  • Adapting MultiPLe Behavior Interventions that eFfectively Improve (AMPLIFI) Cancer Survivor Health- Project 3
  • Adaptive Immunity and Persistent SARS-CoV-2 Replication
  • Admin. Supp to Strengthen NCI-Supported Comm. Outreach Capacity Through Comm. Health Educators (CHEs) of the NON
  • Armed Replicating Ad for Breast Cancer Bone Metastasis
  • BMT Survivor Study-2 (BMTSS-2)
  • Biological Chemistry of Reactive Nitrogen Species Signaling in Cancer Etiology
  • Biological Comparisons Among Three Derivative Models of Glioma Patient Cancers Under Microenvironmental Stress
  • Biological Definition of FCRL Molecules in Malignancy
  • Biomechanical Regulation of Angiogenesis during Tumor Progression
  • Biomechanics of the Stromal Regulation of DCIS
  • C-Src Kinase/Calmodulin Interaction: A Therapeutic Target for Pancreatic Cancer
  • CD147 as a Novel Target in Head and Neck Cancer
  • COMPLETED - Comprehensive Cancer Center Core Support Grant - Clinical Protocol and Data Management Shared Facility
  • COMPLETED - Comprehensive Cancer Center Core Support Grant - Clinical Protocol and Data Management Shared Facility
  • COMPLETED - Comprehensive Cancer Center Core Support Grant - Neuro-Oncology Program
  • COMPLETED - Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership: Biostatistics/Bioinformatics Shared Resource
  • COMPLETED - Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership: Pilot Research Project: IMPaCT 2.0
  • COMPLETED - Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership: Project 1: CD24-Dependent Inactivation of Mutant p53 in Metastatic Castration-Resistant Prostate Cancer
  • COMPLETED - Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership: Project 2: Molecular Regulation of Kaiso in Prostate Cancer
  • Cancer Clinical Investigator Team Leadership Award
  • Cancer Prevention & Control Training Program
  • Cancer Prevention and Control Training Program
  • Canine Immuno Neurotherapeutics
  • Cellular and Biologic Origins in CLL
  • Cervical Cancer Derived Xenografts (PDX) and Organoid Raft Cultures to Evaluate Pathway Specific Therapeutic Agents.
  • Cervical Cancer Prevention in Latina Immigrants
  • Cervical Cancer Preventive Measures Based on HPV 16 Epigenome
  • Characterizing the Role of NOTCH2 in Neuroendocrine Tumors
  • Chemoprevention of Breast Cancer with Rexinoids that Inhibit Obesity-Induced Metabolic Syndrome
  • Collaborative Human Tissue Network
  • Combinatorial Approach for Reducing Invasive Potential of Melanoma Cells
  • Combinatorial Epigenetic-Based Prevention of Breast Cancer
  • Combinatorial Epigenetic-Based Prevention of Breast Cancer
  • Common Variable Immune Deficiency (CVID) Project
  • Completed - Comprehensive Cancer Center Core Support Grant - DNA Sequencing SF
  • Completed - Comprehensive Cancer Center Core Support Grant - HIV Malignancy
  • Completed - Comprehensive Cancer Center Core Support Grant - Micro Array SF
  • Completed - Comprehensive Cancer Center Core Support Grant - NCI Clinical Trials Reporting Program (CTRP)
  • Completed - Comprehensive Genomics Shared Facility - Comprehensive Cancer Center Core Support Grant
  • Comprehensive Approach to Improve Medicine Adherence in Pediatric Leukemia
  • Comprehensive Cancer Center Core Support Grant
  • Comprehensive Cancer Center Core Support Grant
  • Comprehensive Cancer Center Core Support Grant
  • Comprehensive Cancer Center Core Support Grant
  • Comprehensive Cancer Center Core Support Grant
  • Comprehensive Cancer Center Core Support Grant
  • Comprehensive Cancer Center Core Support Grant - Adiministrative Core
  • Comprehensive Cancer Center Core Support Grant - Admin Supplements to Stimulate Research in Non-AIDS Defining Cancers (NADCs) in Aging Populations
  • Comprehensive Cancer Center Core Support Grant - Administration
  • Comprehensive Cancer Center Core Support Grant - Administrative Core
  • Comprehensive Cancer Center Core Support Grant - Administrative Core
  • Comprehensive Cancer Center Core Support Grant - Administrative Core
  • Comprehensive Cancer Center Core Support Grant - Administrative Supplement to Stimulate Research in HIV/AIDS Cancer Research
  • Comprehensive Cancer Center Core Support Grant - Administrative Supplement to Stimulate Research in HIV/AIDS Cancer Research
  • Comprehensive Cancer Center Core Support Grant - Administrative Supplement to Stimulate Research in HIV/AIDS Cancer Research
  • Comprehensive Cancer Center Core Support Grant - Administrative Supplement to Support Participation in the Experimental Therapeutics Clinical Trials Network (ETCTN)
  • Comprehensive Cancer Center Core Support Grant - Administrative Supplements to Strengthen NCI-Supported Community Outreach Capacity through Community Health Educators (CHEs)
  • Comprehensive Cancer Center Core Support Grant - Administrative Supplements to Strengthen NCI-Supported Community Outreach Capacity through Community Health Educators (CHEs) of the National Outreach Network (NON)
  • Comprehensive Cancer Center Core Support Grant - Administrative Supplements to Strengthen NCI-Supported Community Outreach Capacity through Community Health Educators (CHEs) of the National Outreach Network (NON)
  • Comprehensive Cancer Center Core Support Grant - Administrative Supplemet
  • Comprehensive Cancer Center Core Support Grant - Biostatistics and Bioinformatics Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Biostatistics and Bioinformatics Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Biostatistics and Bioinformatics Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Biostatistics and Bioinformatics Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Biostatistics/Bioinformatics
  • Comprehensive Cancer Center Core Support Grant - COVID-19 and Its Implications for Cancer Prevention and Control: A Collaborative Effort Across Cancer Centers (COVID-19 & Cancer Consortium)
  • Comprehensive Cancer Center Core Support Grant - Cancer Cell Biology Program
  • Comprehensive Cancer Center Core Support Grant - Cancer Cell Biology Program
  • Comprehensive Cancer Center Core Support Grant - Cancer Cell Biology Program
  • Comprehensive Cancer Center Core Support Grant - Cancer Cell Biology Program
  • Comprehensive Cancer Center Core Support Grant - Cancer Chemoprevention Program
  • Comprehensive Cancer Center Core Support Grant - Cancer Chemoprevention Program
  • Comprehensive Cancer Center Core Support Grant - Cancer Chemoprevention Program
  • Comprehensive Cancer Center Core Support Grant - Cancer Chemoprevention Program
  • Comprehensive Cancer Center Core Support Grant - Cancer Clinical Investigator Team Leadership Award
  • Comprehensive Cancer Center Core Support Grant - Cancer Clinical Investigator Team Leadership Award (CCITLA)
  • Comprehensive Cancer Center Core Support Grant - Cancer Control and Population Sciences Program
  • Comprehensive Cancer Center Core Support Grant - Cancer Control and Population Sciences Program
  • Comprehensive Cancer Center Core Support Grant - Cancer Control and Population Sciences Program
  • Comprehensive Cancer Center Core Support Grant - Cancer Control and Population Sciences Program
  • Comprehensive Cancer Center Core Support Grant - Cancer Prevention and Control in Rural Alabama: Development of a Participatory and Integrated Action Plan
  • Comprehensive Cancer Center Core Support Grant - Cancer Prevention and Control in Rural Alabama: Development of a Participatory and Integrated Action Plan
  • Comprehensive Cancer Center Core Support Grant - Cancer Prevention and Control in Rural Alabama: Development of a Participatory and Integrated Action Plan
  • Comprehensive Cancer Center Core Support Grant - Cancer Prevention and Control in Rural Alabama: Development of a Participatory and Integrated Action Plan 2.0
  • Comprehensive Cancer Center Core Support Grant - Cancer Prevention and Control in Rural Alabama: Development of a Participatory and Integrated Action Plan 2.0
  • Comprehensive Cancer Center Core Support Grant - Clinical Protocol and Data Management Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Clinical Protocol and Data Management Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Clinical Protocol and Data Management Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Clinical Protocol and Data Management Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Comprehensive Genomics
  • Comprehensive Cancer Center Core Support Grant - Comprehensive Genomics
  • Comprehensive Cancer Center Core Support Grant - Comprehensive Genomics Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Comprehensive Genomics Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Create Access to Targeted Cancer Therapy for Underserved Populations (CATCH-UP)
  • Comprehensive Cancer Center Core Support Grant - Data & Safety Monitoring
  • Comprehensive Cancer Center Core Support Grant - Development
  • Comprehensive Cancer Center Core Support Grant - Development Funds
  • Comprehensive Cancer Center Core Support Grant - Development and Feasibility Testing of a Tobacco Assessment and Cessation Program for Cancer Patients at the O’Neal Comprehensive Cancer Center: Toward Building Capacity
  • Comprehensive Cancer Center Core Support Grant - Developmental Funds
  • Comprehensive Cancer Center Core Support Grant - Developmental Funds
  • Comprehensive Cancer Center Core Support Grant - Developmental Funds
  • Comprehensive Cancer Center Core Support Grant - Developmental Funds
  • Comprehensive Cancer Center Core Support Grant - Early Phase Clinical Research
  • Comprehensive Cancer Center Core Support Grant - Early Phase Clinical Research
  • Comprehensive Cancer Center Core Support Grant - Expanding Distress Screening To Optimize Identification Of Cancer Patients Experiencing Financial Hardship To Enhance Delivery Of Financial Navigation Services
  • Comprehensive Cancer Center Core Support Grant - Expanding Our Cancer Prevention and Control Infrastructure to Reduce Cancer and Other Chronic Disease Health Disparities in the Deep South
  • Comprehensive Cancer Center Core Support Grant - Expanding Our Cancer Prevention and Control Infrastructure to Reduce Cancer and Other Chronic Disease Health Disparities in the Deep South
  • Comprehensive Cancer Center Core Support Grant - Experimental Therapeutics Program
  • Comprehensive Cancer Center Core Support Grant - Experimental Therapeutics Program
  • Comprehensive Cancer Center Core Support Grant - Experimental Therapeutics Program
  • Comprehensive Cancer Center Core Support Grant - Experimental Therapeutics Program
  • Comprehensive Cancer Center Core Support Grant - Experimental Therapeutics Program
  • Comprehensive Cancer Center Core Support Grant - Fabian Supplement (QM-MSP, Ki67, and Cytomorphology of RPFNa Specimens from High Risk Women)
  • Comprehensive Cancer Center Core Support Grant - Gene Expression
  • Comprehensive Cancer Center Core Support Grant - HIV-Associated Malignancies Supplement
  • Comprehensive Cancer Center Core Support Grant - High Field Molecular NMR Shared Facility
  • Comprehensive Cancer Center Core Support Grant - High Resolution Imaging Facility
  • Comprehensive Cancer Center Core Support Grant - High Resolution Imaging Shared Facility
  • Comprehensive Cancer Center Core Support Grant - High Resolution Imaging Shared Facility
  • Comprehensive Cancer Center Core Support Grant - High Resolution Imaging Shared Facility
  • Comprehensive Cancer Center Core Support Grant - High Resolution Imaging Shared Facility
  • Comprehensive Cancer Center Core Support Grant - High Resolution Microscopy (Imaging)
  • Comprehensive Cancer Center Core Support Grant - Human Imaging Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Human Imaging Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Human Imaging Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Human Imaging Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Human Imaging Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Inflammation, Immunology and Immunotherapeutics Program
  • Comprehensive Cancer Center Core Support Grant - Inflammation, Immunology and Immunotherapeutics Program
  • Comprehensive Cancer Center Core Support Grant - Inflammation, Immunology and Immunotherapeutics Program
  • Comprehensive Cancer Center Core Support Grant - Inflammation, Immunology and Immunotherapeutics Program
  • Comprehensive Cancer Center Core Support Grant - Integrating Basic Science And Community Outreach And Engagement To Bridge The Transdisciplinary Cancer Research Continuum
  • Comprehensive Cancer Center Core Support Grant - Major Program Leaders
  • Comprehensive Cancer Center Core Support Grant - Mass Spectrometry and Proteomics Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Mass Spectrometry and Proteomics Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Mass Spectrometry and Proteomics Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Mass Spectrometry and Proteomics Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Mass Spectroscopy
  • Comprehensive Cancer Center Core Support Grant - Microbiome and Gnotobiotics Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Microbiome and Gnotobiotics Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Microbiome and Gnotobiotics Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Microbiome and Gnotobiotics Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Molecular Biology/Rec. Protein
  • Comprehensive Cancer Center Core Support Grant - Molecular NMR
  • Comprehensive Cancer Center Core Support Grant - NCI Clinical Trial Reporting Program (CTRP) Support
  • Comprehensive Cancer Center Core Support Grant - Neuro-Oncology Program
  • Comprehensive Cancer Center Core Support Grant - Neuro-Oncology Program
  • Comprehensive Cancer Center Core Support Grant - Neuro-Oncology Program
  • Comprehensive Cancer Center Core Support Grant - Pilot Projects
  • Comprehensive Cancer Center Core Support Grant - Planning & Evaluation
  • Comprehensive Cancer Center Core Support Grant - Planning and Evaluation
  • Comprehensive Cancer Center Core Support Grant - Planning and Evaluation
  • Comprehensive Cancer Center Core Support Grant - Planning and Evaluation
  • Comprehensive Cancer Center Core Support Grant - Planning and Evaluation
  • Comprehensive Cancer Center Core Support Grant - Population Health Assessment in Cancer Center Catchment Areas
  • Comprehensive Cancer Center Core Support Grant - Population Health Assessment in Cancer Center Catchment Areas
  • Comprehensive Cancer Center Core Support Grant - Population Health Assessment in Cancer Center Catchment Areas
  • Comprehensive Cancer Center Core Support Grant - Preclinical Imaging Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Preclinical Imaging Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Preclinical Imaging Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Preclinical Imaging Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Prevalence and Genotype Distribution of Cervical and Oral HPV Infection in HIV+Brazilian Women
  • Comprehensive Cancer Center Core Support Grant - Proteomics
  • Comprehensive Cancer Center Core Support Grant - Protocol Review and Monitoring System
  • Comprehensive Cancer Center Core Support Grant - Protocol Review and Monitoring System
  • Comprehensive Cancer Center Core Support Grant - Protocol Review and Monitoring System
  • Comprehensive Cancer Center Core Support Grant - Protocol Review and Monitoring System
  • Comprehensive Cancer Center Core Support Grant - Protocol Review and Monitoring System
  • Comprehensive Cancer Center Core Support Grant - Protocol Review/Monitoring
  • Comprehensive Cancer Center Core Support Grant - Protocol Specific
  • Comprehensive Cancer Center Core Support Grant - Recruitment & Retention
  • Comprehensive Cancer Center Core Support Grant - Recruitment and Retention Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Recruitment and Retention Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Recruitment and Retention Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Recruitment and Retention Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Self-Collection & HPV Testing in Unscreened Women: A Feasibility Study in Brazil
  • Comprehensive Cancer Center Core Support Grant - Senior Leadership
  • Comprehensive Cancer Center Core Support Grant - Structural Biology Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Structural Biology Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Structural Biology Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Structural Biology Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Tissue Procurement
  • Comprehensive Cancer Center Core Support Grant - Tissue Procurement Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Tissue Procurement Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Tissue Procurement Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Tissue Procurement Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Tissue Procurement Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Transgenic Animal Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Transgenic Animal Shared Facility
  • Comprehensive Cancer Center Core Support Grant - caBIG Technology Assessment and Implementation Planning
  • Comprehensive Cancer Center Support Grant
  • Comprehensive Cancer Center Support Grant - CCSG Supplement - Mehta - CATCH UP site Transition to EDDOP
  • Comprehensive Cancer Center Support Grant - Administrative Core
  • Comprehensive Cancer Center Support Grant - Animal Imaging Shared Resource
  • Comprehensive Cancer Center Support Grant - Biostatistics & Bioinformatics Shared Resource
  • Comprehensive Cancer Center Support Grant - Cancer Biology & Immunology
  • Comprehensive Cancer Center Support Grant - Cancer Control and Population Sciences
  • Comprehensive Cancer Center Support Grant - Cancer Research Training and Education Coordination
  • Comprehensive Cancer Center Support Grant - Clinical Protocol and Data Management
  • Comprehensive Cancer Center Support Grant - Community Outreach and Engagement
  • Comprehensive Cancer Center Support Grant - Developmental Funds
  • Comprehensive Cancer Center Support Grant - Experimental Therapeutics
  • Comprehensive Cancer Center Support Grant - Experimental Therapeutics
  • Comprehensive Cancer Center Support Grant - Flow Cytometry & Single Cell Analysis Shared Resource
  • Comprehensive Cancer Center Support Grant - Genomics Shared Resource
  • Comprehensive Cancer Center Support Grant - Human Imaging Shared Resource
  • Comprehensive Cancer Center Support Grant - Leadership, Planning, and Evaluation
  • Comprehensive Cancer Center Support Grant - Microbiome Shared Resource
  • Comprehensive Cancer Center Support Grant - Microscopy Shared Resource
  • Comprehensive Cancer Center Support Grant - Neuro-Oncology
  • Comprehensive Cancer Center Support Grant - Participant Recruitment & Assessment Shared Resource
  • Comprehensive Cancer Center Support Grant - Proteomics Shared Resource
  • Comprehensive Cancer Center Support Grant - Protocol Review and Monitoring System
  • Comprehensive Cancer Center Support Grant - Shared Resource Management
  • Comprehensive Cancer Center Support Grant - Structural Biology Shared Resource
  • Comprehensive Cancer Center Support Grant - Tissue Procurement Shared Resource
  • Contemporary Therapeutics for Anaplastic Gliomas
  • Contemporary Therapeutics for Anaplastic Gliomas - Administrative Core
  • Contemporary Therapeutics for Anaplastic Gliomas - Animal Models
  • Contemporary Therapeutics for Anaplastic Gliomas - Brain Tumor Tissue Core
  • Contemporary Therapeutics for Anaplastic Gliomas - Clinical Trials Core
  • Contemporary Therapeutics for Anaplastic Gliomas - Project #1
  • Contemporary Therapeutics for Anaplastic Gliomas - Project #2 - Death Receptor Antibody Therapy for Anaplastic Glioma
  • Cooperative Human Tissue Network
  • Credentialing Murine Models for Glioblastoma Preclinical Drug Development
  • Credentialing Next-generation Human Glioma Models for Precision Therapeutics
  • Cytochrome C Oxidase in Malignant Gliomas
  • Cytoplasmic Multimerization of the RNA-Binding Protein HuR is Oncogenic in Glioma
  • DNA Topoisomerase-Camptothecin Interactions
  • Death Receptor-Mediated Apoptosis and Therapy Strategies in Ovarian Cancer
  • Deciphering How Esco2 Loss Acts as a Penetrance Modifier
  • Deciphering and Targeting a Non-genetic Driver Pathway in Hepatocellular Carcinoma
  • Decision Support Training for Advanced Cancer Family Caregivers: The CASCADE Factorial Trial
  • Deep South Network for Cancer Control
  • Deep South Network for Cancer Control
  • Determining the Influence Genomic Instability During Embryogenesis has on Tumor Penetrance
  • Determining the Structural- and Functional-Level Effects of Diet-Specific Interventions on the Gut Microbiota of a Racially Diverse Sample of Southern United States Adults
  • Developing Novel Combination Therapies for Pancreatic Cancer
  • Developing Therapy for the Treatment of Cholangiocarcinoma
  • Development of Potent and No-toxic Rexinoids to Prevent Non-melanoma Skin Cancer
  • Development, Implementation, and Evaluation of a Smoking Cessation Intervention Tailored to Rural Young Adult African American Men: Toward Scalability
  • Dietary Intervention of Non-Classical Wnt Signaling
  • Discovery of Novel Drug Targets for Breast Cancer
  • Disposable Perfusion Phantom for Accurate DCE-MRI Measurement of Pancreatic Cancer Therapy Response
  • Disposable Perfusion Phantom for Accurate DCE-MRI Measurement of Pancreatic Cancer Therapy Response
  • Dissecting the Myeloid-Th17 axis in the Pathogenesis of Colitis-Associated Colorectal Cancer
  • Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II to Phase III Study
  • ELAVL1 Role in Glioblastoma Heterogeneity Through Intercellular Gene Transfer Mediated by Cell Fusion and Tunneling Membrane Nanotube Formation
  • Early Life Prevention of Breast Cancer with Combined Epigenetic Botanicals
  • Elucidating the Mitochondrial and Nuclear functions of ATP Synthase Subunit ATP5A1 that Maintain Genome Integrity in Response to Oxidative Stress
  • Engineered HSV for the Treatment of Malignant Glioma
  • Engineered HSV for the Treatment of Malignant Glioma - Core A. Administrative Core
  • Engineered HSV for the Treatment of Malignant Glioma - Project 1
  • Engineered HSV for the Treatment of Malignant Glioma - Project 2 - Radiation Enhancement of HSV Anti-Tumor Effects
  • Engineered HSV for the Treatment of Malignant Glioma - Project 3 - Preclinical Evaluation of Oncolytic HSV for Anaplastic Glioma Therapy
  • Engineered HSV for the Treatment of Malignant Glioma - Project 4 - Lessons from the O.R.: Using Clinical Biologic Correlates to Inform HSV Trial Design
  • Enhanced Immunotherapy by Targeting the Pros1:Macrophage Mer Axis
  • Enhancing Physical Activity After Breast Cancer Diagnosis: Randomized Trial
  • Epigenetic contribution to the excess risk of MGUS in African Americans
  • Epigenetics of Tea Polyphenols in Cancer Prevention
  • Evaluating ADGRB3 as a Tumor Suppressor Epigenetically Silenced in WNT Medulloblastoma
  • Evaluating Bioactive Food Components in Obesity and Cancer Prevention
  • Evaluation of Centrosome Amplification as a Risk-predictor for Breast Cancer Aggr
  • Exploring Effects of Weight Loss on Ductal Carcinoma In Situ
  • Exploring the Impact of Negative Energy Balance in Men with Prostate Cancer
  • FOXP3-microRNA146-NFkB Axis in Tumor Suppression
  • Find Your BEAT: Toolkit to Increase Physical Activity in Rural Cancer Survivors
  • Focal Adhesion Kinase (FAK) in Human Neuroblastoma
  • Follicular Regulatory T-cells Promote Cancer
  • Food and Eating Behaviors of Head and Neck Cancer Patients
  • GBM Avatar Screening Paradigm for Rational Pharmacokinomic Glioma Therapy
  • GBM Avatar Screening Paradigm for Rational Pharmacokinomic Glioma Therapy
  • Gene-Engineered and Targeted Stem Cell Therapy for Myeloma
  • Glycan Control of Stem Cell-Associated Pathways in Pancreatic Cancer
  • Glycosylation-dependent Mechanisms Regulating Ovarian Tumor cell Phenotype
  • HPV Clearance by Folic Acid Supplementation
  • HPV Clearance by Folic Acid Supplementation
  • HSET As A Racial Disparity Biomarker for TNBC Patients
  • Harvest for Health in Older Cancer Survivors
  • Heparanase In Tumor Progression, Metastasis and Chemoresistance
  • Heparanase Regulation of Myeloma Metastasis: Mechanism and Therapy
  • Heparanase Regulation of Myeloma Metastasis: Mechanism and Therapy
  • Heparanase Regulation of Osteolysis in Multiple Myeloma
  • Heparanase Regulation of Tumor Host Interactions in Myeloma and Breast Cancer
  • Hijacking the Blimp1-Neuritin Axis to Promote Cancer by Follicular Regulatory T-cells
  • IVR-Supported Interventions for Cancer Prevention in the Deep South
  • Identifying Outcome Mediators of Calorie Restriction Mimetic use in Renal Cancer
  • Identifying a New Biological Target for Breast Cancer Therapy That Contributes to Disparities for African-American Women
  • Imaging Guided Surgery Using Fluorescently Labeled Cetuximab
  • Imaging Guided Surgery using Fluorescently Labeled Cetuximab
  • Imaging for Assessment and Prediction of Response to Therapy for Triple Negative Breast Cancer
  • Implementation of a Provider-Focused Intervention for Maximizing HPV Vaccine Uptake in Young Cancer Survivors receiving Follow-Up Care in Pediatric Oncology Practices: A Cluster-Randomized Trial
  • Implementing Palliative Care: Learning Collaborative vs. Technical Assistance
  • Inhibin Function in Tumor Angiogenesis
  • Inhibiting Multiple Molecular Targets for Preventing Non-Melanoma Skin Cancer
  • Integrated Smoking Cessation Treatment for Low Income Community Corrections
  • Interaction between the Epitranscriptome and Metabolism in L-2HG Driven Kidney Cancer
  • Intra-Tumor Heterogeneity in Colorectal Cancer Progression and Treatment Response
  • Lay Coach-led Early Palliative Care for Underserved Advanced Cancer Caregivers
  • Leukemia Stem Cell Regulation and Resistance
  • Life after Breast Cancer Treatment: Racial Health Disparities and Chronic Pain in Breast Cancer Survivors
  • Linking Nucleotide and Amino Acid Metabolism to Cholesterol Synthesis by MYCN
  • Loss of FLJ13639 Expression in Acute Leukemia
  • Loss of NF1 drives Hormone Dependent Mammary Carcinogenesis in a Rat Model with Intact Immune System
  • Low Dose Tamoxifen in Hodgkin Lymphoma Survivors for Breast Cancer Risk
  • MEF2D-Mediated Transcriptional Control of Acute Myeloid Leukemia
  • Maternal Epigenetic Dietary Effects on Early Breast Cancer Prevention
  • Maternal Epigenetic Dietary Effects on Early Breast Cancer Prevention
  • Maternal Epigenetic Dietary Effects on Early Breast Cancer Prevention
  • Mathematical Modeling and Molecular Imaging to Maximize Response While Minimizing Toxicities from Systemic Therapies in Preclinical Models of Breast Cancer
  • Mechanisms of Human Papillomavirus DNA Replication
  • Mechanisms of Human Papillomavirus DNA Replication
  • Mechanisms of Resistance to Cancer Therapeutics
  • Medical Record Abstraction for Pancreatic Cancer Survival Analyses
  • MicroRNAs for Monitoring Tumor Progression and Predicting Response to Therapy
  • Microbiome Based Approach to Identify the Progression Potential of CIN 2 Lesions
  • Microenvironmental Regulation Of Leukemia Stem Cells
  • Microenvironmental Regulation of Glioblastoma Angiogenesis via CHD7
  • Microenvironmental Regulation of Leukemia Stem Cells
  • Mitigating Long-term Treatment-related Morbidity in Childhood Cancer Survivors
  • Mitochondria and Carcinogenesis
  • Mitochondria and Mutagenesis
  • Mitochondria in Prostate Cancer Diversity
  • Mitochondrial DNA and Prostate Cancer in African Americans
  • Modeling Dynamic Immune Cell Modulation in a 3-D Tissue Engineered Platform to Enhance Patient-specific Immunotherapy for Lung Cancer
  • Molecular Characterization of Myeloma and Related Asymptomatic Precursor States
  • Molecular Determinants of Breast Cancer Malignancy
  • Molecular Predictors of Post-Mastectomy Breast Cancer Loco-Regional Recurrence
  • Molecular Therapeutics for Anaplastic Gliomas
  • Molecular Therapeutics for Anaplastic Gliomas - Core C
  • Molecular Therapeutics for Anaplastic Gliomas - Project 3
  • Molecular Therapeutics for Anaplastic Gliomas - Project 4
  • Morehouse School of Medicine/Tuskegee University/Univ. of Alabama Cancer Center Partnership
  • Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership
  • Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership: (Admin Supplement) to Support Development of PDX at UAB CCC
  • Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership: Administrative Core
  • Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership: Bioethics Shared Resource
  • Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership: Biostatistics/Bioinformatics Shared Resource
  • Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership: Outreach Core
  • Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership: Planning and Evaluation Core
  • Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership: Research Education Core
  • Multi-Modal Lysosomotropic Death Therapy for Malignant Peripheral Nerve Sheath Tumors
  • Multimodal Study Of Cognitive Impairment Following Radiation Therapy for Locally Advanced Head And Neck Cancer
  • Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults with Colorectal Cancer: The M&M Study
  • NCI-CONNECT (Comprehensive Oncology Network Evaluating Rare CNS Tumors) Collaborative Agreement
  • NCTN Deep South Research Consortium
  • NCTN Deep South Research Consortium
  • NCTN Deep South Research Consortium
  • NCTN Deep South Research Consortium
  • Nanodelivery Platform for Antibody Drugs Targeting NHL
  • Negative Impact of RNA Destabilizer Tristetraprolin on Glioma Growth
  • Novel Anti-HER3 Strategy for Pancreatic Cancer
  • Novel Combinatorial Therapeutic Approach for Prostate Cancer
  • Novel Fluorinated Amino Ester Prodrugs For PET Imaging Of Gliomas
  • Novel Heparanase Inhibitors for Cancer Therapy
  • Novel Role for Shed Syndecan 1 in Promoting an Aggressive Tumor Phenotype
  • Novel Treatment of NF-1 Associated Malignant Peripheral Nerve Sheath Tumors
  • Nucleoporin NUP205-Driven Novel Pathway in Melanoma Tumor Growth and Metastasis
  • Obesity Affects Immunity to Kidney Cancer
  • Oncolytic Immunotherapy Using Chimeric HSV C134: A Phase I Trial and Establishment of Response Indicators in Recurrent Glioma Patients
  • Optical Imaging of Primary and Regional Melanoma to Guide Surgical Resection
  • Osteopontin and Microenvironment of Initiated Cells
  • Overcoming Tumor-Intrinsic Therapeutic Resistance to Immunotherapies
  • PRMT1-Mediated Metabolic Reprogramming in Leukemia Progression
  • PTP1b Inhibition Restores the Innate Anti-tumor Response During Chemotherapy
  • Participatory Design of a Text Message System to Support Community Health Advisor
  • Personalized Therapy for p16-deficient Melanoma
  • Personalizing Immunotherapy in HER2+ Breast Cancer through Quantitative Imaging
  • Pet Tumor and Proliferation Imaging Via Cationic Amino Acid Transport
  • Phase-Sensitive X-Ray Breast Tomosynthesis (R09-003)
  • Plumbagin in Combination with Vemurafenib for BRAF-Mutant Melanoma
  • Post-Transcriptional Regulation Requires Phosphorylation of HuR in Gliomas
  • Precision Metabolic Therapy of p53 Mutant Triple Negative Breast Cancers
  • Predictive Molecular Markers of Colorectal Cancer
  • Predictors of Systemic Exposure to Oral 6MP During Maintenance in Adolescents and Young Adults with Acute Lymphoblastic Leukemia
  • Prevention of UV-Carcinogenesis Through DNA Methylation-Dependent Immunomodulation
  • Prevention of UV-Carcinogenesis through DNA Repair-Dependent Immunomodulation
  • Promoting Weight-Loss in African American Cancer Survivors in the Deep South
  • Prostate, Lung, Colo-Rectal and Ovarian (PLCO) Cancer Screening Trial
  • Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial - Prostate Cancer Progression in the PLCO Cancer Screening Trial
  • Protein Interactions Underlying Fas-Mediated DISC in Cholangiocarcinoma
  • Quadrivalent Human Papillomavirus (HPV) Vaccine in Cancer Survivors
  • Quantitative PET Imaging for Oncologic Immune Response Prediction
  • RHYTHM: Restoring Health in You (and Your Partner) Through Movement
  • RNA Epigenetic Regulation of Cancer Metabolism
  • RXR Rexinoids for Cancer Chemoprevention
  • RXR Rexinoids for Cancer Chemoprevention - Project 2: Design and Development of Third Generation RXR Rexinoids as Potential Chemoprevention Agents
  • RXR Rexinoids for Cancer Chemoprevention - Core 1: Administrative Core
  • RXR Rexinoids for Cancer Chemoprevention - Core 2: RXR Rexinoid Design and Synthesis
  • RXR Rexinoids for Cancer Chemoprevention - Core 3: Rexinoid Screening and Animal Core
  • RXR Rexinoids for Cancer Chemoprevention - Program Integration and Management
  • RXR Rexinoids for Cancer Chemoprevention - Project 1: Evaluation if UAB30 on Skin Cancer Biomarkers in Human Renal Transplant Recipients
  • RXR Rexinoids for Cancer Chemoprevention - Project 2: Design and Development of Third Generation RXR Rexinoids as Potential Chemoprevention Agents
  • RXR Rexinoids for Cancer Chemoprevention - Project 3: Molecular Targets of Rexinoid Action in Skin
  • Racial Disparities: Pain in Women Treated for Breast Cancer
  • Radiolabeled Antibodies Targeting LAT1 for Imaging and Therapy of Prostate Cancer
  • Reduction of Tumor-Positive Margins in Oncology Surgery
  • Regulation of Beta1 Integrin Glycosylation by Ras
  • Regulation of Polycomb Repressive Complex 1 by EZH2 Regulated microRNAs in Cancer
  • Regulation of the Kidney Cancer Epigenome by Oncometabolite L-2-Hydroxyglutarate
  • Research Training Program in Basic and Translational Oncology
  • Research Training Program in Basic and Translational Oncology
  • Research Training Program in Surgical Oncology
  • Research Training Program in Surgical Oncology
  • Research Training Program in Surgical Oncology
  • Resistance of CML Stem Cells to Imatinib (Gleevec)
  • Roadmap for America's Cancer Explorers for the 21st Century (RACE21)
  • Role of Fumarate Hydratase in Renal Hypoxia and Tumorigenesis
  • Role of Genetic Susceptibility in Therapy-Related Subsequent Malignancies
  • Role of Gut Microbe Composition in Psychosocial Symptom Response to Exercise Training in Breast Cancer Survivors
  • Role of Microbiota in Therapy to Ovarian Cancer
  • Role of NF-kB in Hematopoietic Stem Cells and Leukemia-Initiating Cell Formation
  • Role of NMI in Retarding Breast Tumor Growth
  • Role of O-GlcNAc-ylation on Tumor Progression
  • Role of Oncometabolite L-2 Hydroxyglutarate in Reprogramming Renal Cell Carcinoma Metabolism
  • Role of Transcriptional Corepressor CtBP1 in Prostate Cancer Progression
  • Roles of Semaphorin Signaling in Breast Cancer Racial Disparities
  • Rural Breast Cancer Survivors Intervention
  • SON-Mediated Gene Expression and Leukemia
  • SON-Mediated RNA Splicing in Glioblastoma
  • SPORE in Breast Cancer
  • SPORE in Breast Cancer - Administrative Core
  • SPORE in Breast Cancer - Biostatistics Core
  • SPORE in Breast Cancer - Career Development
  • SPORE in Breast Cancer - Diversity Supplement
  • SPORE in Breast Cancer - Pilot Projects
  • SPORE in Breast Cancer - Project 1
  • SPORE in Breast Cancer - Project 2
  • SPORE in Breast Cancer - Project 3
  • SPORE in Breast Cancer - Project 4
  • SPORE in Breast Cancer - Project 5
  • SPORE in Breast Cancer - Tissue Core
  • ST6Gal-1 Contributes To Pancreatic Cancer Initiation by Promoting Pancreatitis-Induced Acinar To Ductal Metaplasia
  • STRAP and Smad 7 Signaling in Colorectal Carcinomas
  • SUMOylation and Cell Sensitivity to Top1 Poisons
  • Sialylation-dependent Mechanisms Driving Pancreatic Cancer Progression
  • Somatostatin Receptor 2 (SSTR2) Antibody-drug Conjugate for Pancreatic Neuroendocrine Tumor (PanNet) Therapy
  • Sowing the Seeds of Health: A Program for Latinas
  • Studies on ORC and Double Strand DNA Break Repair
  • Surgical Oncology Research Training Program
  • Surgical Oncology Research Training Program
  • Synergistic Targeted Therapy of Antibody-Drug Conjugates for Triple-Negative Breast Cancer
  • TGF-beta Polymorphisms and Breast Cancer in Families
  • TGFBR1 Signaling in Colorectal Cancer
  • Targeted Delivery of Multimodal Therapy for Reducing Prostate Cancer Disparity
  • Targeted Neuroendocrine Cancer Therapy using Verrucarin A
  • Targeted Therapy for Breast Cancer with Osteolytic Bone Damage
  • Targeted Treatment of Metastatic Gastroenteropancreatic Neuroendocrine Tumors
  • Targeting Adaptive Radioresistance of Glioblastoma
  • Targeting Metabolic Checkpoints in the Tumor Microenvironment to Boost Efficacy of Anti-CTLA-4
  • Targeting the JAK/STAT-3 Pathway Signaling Axis in Glioma
  • Testing Scalable, IVR-Supported Cancer Prevention Interventions in the Rural Alabama Black Belt
  • The Interplay of Behavior, Environment, and Microbiota in Colorectal Cancer Risk
  • The National Cancer Institute Serology Network Agreement
  • The Natural History of CMV-Related Hearing Loss and the Feasibility of CMV Screening as Adjunct to Hearing Screening in the Newborn
  • The Role of CK2 in Glioblastoma Development
  • The Role of Exosome Heparanase and miRNAs as Biomarkers for Myeloma
  • The Role of Small RNA Modifications in Glioma
  • The Role of a Histone Point Mutation in Pediatric Gliomagenesis
  • The Roles of SOCS5 In T-ALL Migration and Tissue Infiltration
  • The Thrombospondin1-TGF-Beta Axis in Multiple Myeloma
  • Therapy of Pancreatic Cancer With 212Pb-Labeled B7-H3 Specific Ab and LDE225
  • Third International Meeting on Genetic Syndromes of the Ras/MAPK Pathway
  • Topical Chemoprevention of Skin Cancer Biomarkers
  • Transplanting Unique Human Microbiomes to Improve Immunotherapy in Glioblastoma
  • Tumorigenic Role of Mitochondria in African-American Women
  • UAB / UMN SPORE in Pancreatic Cancer
  • UAB / UMN SPORE in Pancreatic Cancer - Career Development
  • UAB / UMN SPORE in Pancreatic Cancer - Core A
  • UAB / UMN SPORE in Pancreatic Cancer - Core B
  • UAB / UMN SPORE in Pancreatic Cancer - Core C
  • UAB / UMN SPORE in Pancreatic Cancer - Core D
  • UAB / UMN SPORE in Pancreatic Cancer - Development
  • UAB / UMN SPORE in Pancreatic Cancer - Project 1
  • UAB / UMN SPORE in Pancreatic Cancer - Project 2
  • UAB / UMN SPORE in Pancreatic Cancer - Project 3
  • UAB / UMN SPORE in Pancreatic Cancer - Project 4
  • UAB Cancer Prevention and Control Training Program (T32)
  • UAB Cancer Prevention and Control Training Program (T32)
  • UAB Cancer Research Experiences for Students
  • UAB Cancer Research Experiences for Students (CaRES)
  • UAB Comprehensive Cancer Center Early Stage Investigator Recruitment
  • UAB-Tuskegee Faculty Institutional Recruitment for Sustainable Transformation Partnership (UAB-TU FIRST Partnership) - ADMIN Core
  • UAB-Tuskegee Faculty Institutional Recruitment for Sustainable Transformation Partnership (UAB-TU FIRST Partnership) - ADMIN Core
  • UAB-Tuskegee Faculty Institutional Recruitment for Sustainable Transformation Partnership (UAB-TU FIRST Partnership) - Evaluation Core
  • UAB-Tuskegee Faculty Institutional Recruitment for Sustainable Transformation Partnership (UAB-TU FIRST Partnership) - Faculty Development Core
  • UAB-Tuskegee Faculty Institutional Recruitment for Sustainable Transformation Partnership (UAB-TU FIRST Partnership) - Faculty Development Core
  • UAB-Tuskegee Faculty Institutional Recruitment for Sustainable Transformation Partnership (UAB-TU FIRST Partnership) -Evaluation Core
  • UAB/Tuskegee Faculty Institutional Recruitment for Sustainable Transformation (UAB/TU FIRST) Partnership (NIH U54)
  • UAB/Tuskegee Faculty Institutional Recruitment for Sustainable Transformation (UAB/TU FIRST) Partnership (NIH U54)
  • Understanding Rural Mortality Disparities in Cancer: A Multi-Level Approach
  • Urinary Metabolites of Cranberry that Protect against Bladder Cancer
  • Utilizing microRNA-146a to Block Triple-Negative Breast Cancer Cell Colonization
  • Validating a Novel Biomarker of Clinical Progression and Survival in CLL
  • Vegetable Garden Feasibility Trial to Promote Function in Older Cancer Survivors
  • Wnt5a and TGF-beta in Mammary Development and Cancer
  • Zambian Cervical Cancer Research Capacity Initiative
  • rAAV Vaccine Vector